- Home
- PROV vs MIST Comparison
PROV vs MIST Comparison
Compare PROV & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- MIST
- Stock Information
- Founded
- PROV 1956
- MIST 2003
- Country
- PROV United States
- MIST Canada
- Employees
- PROV N/A
- MIST N/A
- Industry
- PROV Savings Institutions
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- PROV Finance
- MIST Health Care
- Exchange
- PROV Nasdaq
- MIST Nasdaq
- Market Cap
- PROV 107.2M
- MIST 103.4M
- IPO Year
- PROV 1996
- MIST N/A
- Fundamental
- Price
- PROV $16.04
- MIST $1.97
- Analyst Decision
- PROV Hold
- MIST Strong Buy
- Analyst Count
- PROV 1
- MIST 3
- Target Price
- PROV $16.00
- MIST $13.00
- AVG Volume (30 Days)
- PROV 7.4K
- MIST 700.9K
- Earning Date
- PROV 01-28-2025
- MIST 03-20-2025
- Dividend Yield
- PROV 3.49%
- MIST N/A
- EPS Growth
- PROV N/A
- MIST N/A
- EPS
- PROV 0.91
- MIST N/A
- Revenue
- PROV $38,443,000.00
- MIST N/A
- Revenue This Year
- PROV N/A
- MIST N/A
- Revenue Next Year
- PROV $11.75
- MIST N/A
- P/E Ratio
- PROV $17.64
- MIST N/A
- Revenue Growth
- PROV N/A
- MIST N/A
- 52 Week Low
- PROV $12.01
- MIST $1.12
- 52 Week High
- PROV $16.70
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- PROV 56.92
- MIST 47.49
- Support Level
- PROV $15.00
- MIST $1.92
- Resistance Level
- PROV $16.29
- MIST $2.13
- Average True Range (ATR)
- PROV 0.50
- MIST 0.14
- MACD
- PROV 0.11
- MIST -0.02
- Stochastic Oscillator
- PROV 84.66
- MIST 22.22
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).